平成25年度採択 文部科学省 私立大学戦略的研究基盤形成支援事業『生体分子情報による次世代型がん個別最適化治療法の開発』(事業番号S1311016)にかかる医学総合研究所第1回国際シンポジウム"Role of Aging and Cancer"を開催いたします。
日時 平成29年8月28日(月) 14:00~19:00
会場 東京医科大学病院 教育研究棟 3階 大教室(アクセス)
 プログラム  ポスター拡大はこちら>>
 Opening Remarks
 Prof. Mamoru Suzuki (President of Tokyo Medical University)
Session 1
 (1) miRNA in aging and cancer: Prof. Hidetoshi Tahara (Hiroshima University)
 (2) Dendritic cell-derived exosomes as Immunotherapy: Dr. Masakatsu Takanashi (Tokyo Medical University)
 (3) Cross-talk mediated by bone marrow stromal cell-derived extracellular vesicles: Dr. Tomohiro Umezu (Tokyo Medical University)
 (4) Clinical application of mesenchymal stromal cells (Kintaro cellsTM): Mr. Alexei Gladkov (Kintaro Cells Power Corp.)
 Session 2
 (5) Advances in cancer immunotherapy:Prof. Takayuki Yoshimoto (Tokyo Medical University)
 (6) Hypoxia induced paclitaxel resistance via miR-100 as a potential diagnostic biomarker for cervical cancer:Prof. Hirotaka Nishi (Tokyo Medical University) 
 (7) G-quadruplexes in cancer biology and therapeutics:Dr. Hiroyuki Seimiya (Japanese Foundation for Cancer Research)
 (8) Recent advance of telomere biology in neuroblastoma:Prof. Eiso Hiyama (Hiroshima University)
 Special Lecture
 Recent advances in telomeres and telomerase in relation to aging and cancer: TeSLA, TPE-OLD and 6-thio-2'-deoxyguanosine
 Prof. Jerry W. Shay(Department of Cell Biology, University of Texas Southwestern Medical Center, Dallas, U.S.A)
 Chair: Prof. Kazuma Ohyashiki (Tokyo Medical University)
このニュースに関するお問い合わせ
お問い合わせ:Chikako Kato (Secretariat of the 1st TMU-IMS International Symposium in Tokyo)
 E-mail: s-idrc@tokyo-med.ac.jp
TEL&FAX: +81-3-3345-0185
[URL] http://team.tokyo-med.ac.jp/ims_onc/symposium/index.html
